Actuate Therapeutics Inc

NASDAQ: ACTU · Real-Time Price · USD
8.36
0.24 (2.96%)
At close: Aug 18, 2025, 2:54 PM

Actuate Therapeutics Inc Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Net Income
-6.32M -6.45M -5.97M -6.57M -8.3M -7.61M -6.34M -5.52M -5.27M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
1.13M 1.19M 565.98K 90.02K 148.21K 122.05K 155.23K 73.13K 73.13K
Other Working Capital
n/a 779.91K -792.56K 734.39K 1.88M 1.06M 336.76K 541.52K -653.75K
Other Non-Cash Items
n/a 5.08K 658.73K 1.15M 537.59K 56.66K -11.8K -206.6K 492.03K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a 477.01K -4.4M 2.66M 2.36M 1.92M 556.25K 541.52K -653.75K
Operating Cash Flow
-4.62M -4.77M -9.15M -2.67M -5.25M -5.51M -5.64M -5.12M -5.36M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Debt Repayment
n/a -5.5M n/a 1M 4.5M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-133.48K 4.91M 22.32M -42.96K -142.77K n/a n/a 1.67M 2.46M
Financial Cash Flow
-133.48K -109.41K 22.32M 957.04K 4.36M n/a n/a 1.67M 2.46M
Net Cash Flow
-4.75M -4.88M 13.17M -1.72M -890.35K -5.51M -5.64M -3.45M 17.55M
Free Cash Flow
-4.62M -4.77M -9.15M -2.67M -5.25M -5.51M -5.64M -5.12M -5.36M